JPY2,483.50
2.10% today
Tokyo, May 21, 05:46 am CET
ISIN
JP3351100007
Symbol
6869
Sector

SYSMEX Stock price

JPY2,432.50
-252.00 9.39% 1M
-639.50 20.82% 6M
-484.00 16.60% YTD
-335.00 12.10% 1Y
-220.55 8.31% 3Y
-293.20 10.76% 5Y
+123.04 5.33% 10Y
Tokyo, Closing price Tue, May 20 2025
+3.00 0.12%
ISIN
JP3351100007
Symbol
6869
Sector

Key metrics

Market capitalization JPY1.52t
Enterprise Value JPY1.49t
P/E (TTM) P/E ratio 28.26
EV/FCF (TTM) EV/FCF 25.29
EV/Sales (TTM) EV/Sales 2.93
P/S ratio (TTM) P/S ratio 2.98
P/B ratio (TTM) P/B ratio 3.27
Dividend yield 1.48%
Last dividend (FY26) JPY38.00
Revenue growth (TTM) Revenue growth 10.21%
Revenue (TTM) Revenue JPY508.64b
EBIT (operating result TTM) EBIT JPY89.68b
Free Cash Flow (TTM) Free Cash Flow JPY59.02b
Cash position JPY89.57b
EPS (TTM) EPS JPY86.05
P/E forward 24.42
P/S forward 2.79
EV/Sales forward 2.74
Show more

Is SYSMEX a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

SYSMEX Stock Analysis

Unlock Scores for Free

Analyst Opinions

17 Analysts have issued a SYSMEX forecast:

13x Buy
76%
4x Hold
24%

Analyst Opinions

17 Analysts have issued a SYSMEX forecast:

Buy
76%
Hold
24%

Financial data from SYSMEX

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
508,643 508,643
10% 10%
100%
- Direct Costs 236,665 236,665
8% 8%
47%
271,978 271,978
12% 12%
53%
- Selling and Administrative Expenses 111,815 111,815
14% 14%
22%
- Research and Development Expense 31,455 31,455
0% 0%
6%
128,708 128,708
14% 14%
25%
- Depreciation and Amortization 39,033 39,033
9% 9%
8%
EBIT (Operating Income) EBIT 89,675 89,675
16% 16%
18%
Net Profit 53,669 53,669
8% 8%
11%

In millions JPY.

Don't miss a Thing! We will send you all news about SYSMEX directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Sysmex Corp. engages in the healthcare business. It develops, manufactures, sells, exports, and imports diagnostic instruments, reagents. and software used in in-vitro diagnostics. It also provides clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. It operates through the following geographical segments: Japan, Americas, Europe, Middle East, and Africa (EMEA), China, and Asia Pacific. The company was founded by Taro Nakatani on February 20, 1968 and is headquartered in Kobe, Japan.

Head office Japan
CEO Hisashi Ietsugu
Founded 1968
Website www.sysmex.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today